Business Context and Reporting Period
This Form 8-K Current Report was filed by National Research Corporation (NRC Health) on April 18, 2025. The filing addresses Item 5.02 regarding the departure, election, or appointment of certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes.
Material Changes
The primary material change reported is the restructuring of the Company's executive leadership team effective April 18, 2025:
- Michael D. Hays: Designated as the Company's Principal Financial Officer (PFO) in addition to his existing role as Chief Executive Officer (CEO). He will continue as CEO until June 1, 2025.
- Jordan N. Freeman: Appointed as Chief Accounting Officer (CAO) and Principal Accounting Officer. She joined the Company in April 2025 as Vice President, Finance Operations.
- Trent Green: Scheduled to join the Company as the new Chief Executive Officer on June 1, 2025.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It notes that there were no compensation changes in connection with the appointments of Mr. Hays or Ms. Freeman. The report highlights Ms. Freeman's background as a Certified Public Accountant with prior experience at Nelnet, Inc., Deloitte & Touche LLP, and HBE Becker Meyer Love, LLP.
Investor Verification Checklist
- Confirm the exact transition date for Trent Green assuming the CEO role (June 1, 2025).
- Verify the duration of Michael D. Hays' dual role as CEO and PFO.
- Review subsequent filings for any compensation agreements related to the new appointments, as none were disclosed in this report.
- Monitor future 10-Q or 10-K filings for the first financial results under the new leadership structure.